Report for Rosenson RS

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (3)

Title : Severe hypertriglyceridemia: Existing and emerging therapies - Malick_2023_Pharmacol.Ther__108544
Author(s) : Malick WA , Do R , Rosenson RS
Ref : Pharmacol Ther , :108544 , 2023
Abstract : Malick_2023_Pharmacol.Ther__108544
ESTHER : Malick_2023_Pharmacol.Ther__108544
PubMedSearch : Malick_2023_Pharmacol.Ther__108544
PubMedID: 37848164

Title : Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial - Rosenson_2023_Nat.Med__
Author(s) : Rosenson RS , Gaudet D , Ballantyne CM , Baum SJ , Bergeron J , Kershaw EE , Moriarty PM , Rubba P , Whitcomb DC , Banerjee P , Gewitz A , Gonzaga-Jauregui C , McGinniss J , Ponda MP , Pordy R , Zhao J , Rader DJ
Ref : Nat Med , : , 2023
Abstract : Rosenson_2023_Nat.Med__
ESTHER : Rosenson_2023_Nat.Med__
PubMedSearch : Rosenson_2023_Nat.Med__
PubMedID: 36879129
Gene_locus related to this paper: human-LPL

Title : Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2 - Rosenson_2012_J.Lipid.Res_53_1767
Author(s) : Rosenson RS , Stafforini DM
Ref : J Lipid Res , 53 :1767 , 2012
Abstract : Rosenson_2012_J.Lipid.Res_53_1767
ESTHER : Rosenson_2012_J.Lipid.Res_53_1767
PubMedSearch : Rosenson_2012_J.Lipid.Res_53_1767
PubMedID: 22665167